Dimed Distribuidora de Medicamentos (BSP:PNVL3) Cyclically Adjusted Revenue per Share: R$30.44 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:PNVL3 Dimed SA Distribuidora de Medicamentos BSP:PNVL3
89 GF Score
Price R$11.78
GF Value R$13.74
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Dimed Distribuidora de Medicamentos Cyclically Adjusted Revenue per Share?

Dimed Distribuidora de Medicamentos BSP:PNVL3 +0.43% 89 Cyclically Adjusted Revenue per Share is R$30.44 as of Mar. 2026. GuruFocus rates BSP:PNVL3 with a GF Score™ of 89/100 and a GF Value™ of R$13.74 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Dimed Distribuidora de Medicamentos's adjusted revenue per share for the three months ended in Mar. 2026 was R$9.666. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$30.44 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Dimed Distribuidora de Medicamentos's average Cyclically Adjusted Revenue Growth Rate was 0.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 5.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Dimed Distribuidora de Medicamentos was 5.20% per year. The lowest was 4.80% per year. And the median was 4.90% per year.

As of today (2026-07-24), Dimed Distribuidora de Medicamentos's current stock price is R$11.78. Dimed Distribuidora de Medicamentos's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$30.44. Dimed Distribuidora de Medicamentos's Cyclically Adjusted PS Ratio of today is 0.39.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dimed Distribuidora de Medicamentos was 0.96. The lowest was 0.27. And the median was 0.43.


Dimed Distribuidora de Medicamentos  (BSP:PNVL3) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dimed Distribuidora de Medicamentos's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=11.78/30.44
=0.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dimed Distribuidora de Medicamentos was 0.96. The lowest was 0.27. And the median was 0.43.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Dimed Distribuidora de Medicamentos Cyclically Adjusted Revenue per Share Related Terms


Dimed Distribuidora de Medicamentos Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Dimed Distribuidora de Medicamentos's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dimed Distribuidora de Medicamentos Cyclically Adjusted Revenue per Share Chart

Dimed Distribuidora de Medicamentos Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.56 25.34 27.26 29.41 29.54

Dimed Distribuidora de Medicamentos Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.25 30.84 31.34 29.54 30.44

BSP:PNVL3 vs LLY, JNJ, ABBV: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - General subindustry, Dimed Distribuidora de Medicamentos's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dimed Distribuidora de Medicamentos Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dimed Distribuidora de Medicamentos's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dimed Distribuidora de Medicamentos's Cyclically Adjusted PS Ratio falls into.


BSP:PNVL3
89GF Score
Dimed SA Distribuidora de Medicamentos BSP:PNVL3
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dimed Distribuidora de Medicamentos Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dimed Distribuidora de Medicamentos's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.666/175.0655*175.0655
=9.666

Current CPI (Mar. 2026) = 175.0655.

Dimed Distribuidora de Medicamentos Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.712 108.851 5.970
201609 3.781 109.986 6.018
201612 4.163 110.802 6.577
201703 3.994 111.869 6.250
201706 4.003 112.115 6.251
201709 4.173 112.777 6.478
201712 7.139 114.068 10.957
201803 4.177 114.868 6.366
201806 4.270 117.038 6.387
201809 4.511 117.881 6.699
201812 4.791 118.340 7.088
201903 4.708 120.124 6.861
201906 4.451 120.977 6.441
201909 5.089 121.292 7.345
201912 5.524 123.436 7.835
202003 5.250 124.092 7.407
202006 3.663 123.557 5.190
202009 4.945 125.095 6.920
202012 4.282 129.012 5.811
202103 5.005 131.660 6.655
202106 5.358 133.871 7.007
202109 5.127 137.913 6.508
202112 5.787 141.992 7.135
202203 6.125 146.537 7.317
202206 6.755 149.784 7.895
202209 6.690 147.800 7.924
202212 7.242 150.207 8.441
202303 6.909 153.352 7.887
202306 7.363 154.519 8.342
202309 7.647 155.464 8.611
202312 8.197 157.148 9.132
202403 8.405 159.372 9.233
202406 6.629 161.052 7.206
202409 8.273 162.342 8.921
202412 9.025 164.740 9.591
202503 8.379 168.102 8.726
202506 8.901 169.670 9.184
202509 9.218 170.739 9.452
202512 10.500 171.765 10.702
202603 9.666 175.066 9.666

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$30.44 mean?
Dimed Distribuidora de Medicamentos (BSP:PNVL3) has a Cyclically Adjusted Revenue per Share of R$30.44 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dimed Distribuidora de Medicamentos and its competitors.
Is Dimed Distribuidora de Medicamentos' Cyclically Adjusted Revenue per Share too high?
Dimed Distribuidora de Medicamentos' current Cyclically Adjusted Revenue per Share is R$30.44. Overall, Dimed Distribuidora de Medicamentos has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dimed Distribuidora de Medicamentos' Cyclically Adjusted Revenue per Share compare to LLY and JNJ?
Dimed Distribuidora de Medicamentos' Cyclically Adjusted Revenue per Share of R$30.44 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Dimed Distribuidora de Medicamentos and its competitors. Dimed Distribuidora de Medicamentos's current Cyclically Adjusted Revenue per Share is R$30.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimed Distribuidora de Medicamentos stock overvalued right now?
Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos (BSP:PNVL3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$13.74, compared to a current price of R$11.78 — trading 14.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$30.44. Dimed Distribuidora de Medicamentos' overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Dimed Distribuidora de Medicamentos (BSP:PNVL3), the current Cyclically Adjusted Revenue per Share is R$30.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dimed Distribuidora de Medicamentos (BSP:PNVL3) Overvalued in 2026?

Based on GuruFocus' analysis, Dimed Distribuidora de Medicamentos stock appears to be undervalued. The current stock price of R$11.78 is trading 14.3% below its estimated GF Value™ of R$13.74. GuruFocus considers Dimed Distribuidora de Medicamentos to be Modestly Undervalued.

Key valuation signals for BSP:PNVL3:

  • Cyclically Adjusted Revenue per Share: R$30.44
  • GF Value™: R$13.74 vs. price of R$11.78 (14.3% below fair value)
  • GF Score™: 89/100 with 5 warning signs

No single metric tells the full story. See the BSP:PNVL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dimed Distribuidora de Medicamentos Business Description

Address Avenida Industrial Belgraf, 865, Eldorado do Sul, RS, BRA, 92990-000
Dimed SA Distribuidora de Medicamentos is engaged in the sale of medicines, perfumery, personal care and beauty products, cosmetics and dermocosmetics. It has single reportable segment that is, The Retail segment. The Retail segment has 556 stores that sell more than 15,000 items among drugs and personal care and beauty products. In addition to adding divisions of cosmetics, drugs and food, Lifar is responsible for the production of brands in Brazil, as well as products of its own brand Panvel.
89GF Score

Get the complete analysis for BSP:PNVL3

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$11.78
Price
R$13.74
GF Value